These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

580 related items for PubMed ID: 19361675

  • 1. [Cognitive impairment].
    Reuter F, Audoin B, Rico A, Malikova I, Ranjeva JP, Pelletier J.
    Rev Neurol (Paris); 2009 Mar; 165 Suppl 4():S113-22. PubMed ID: 19361675
    [Abstract] [Full Text] [Related]

  • 2. Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations.
    Rogers JM, Panegyres PK.
    J Clin Neurosci; 2007 Oct; 14(10):919-27. PubMed ID: 17659875
    [Abstract] [Full Text] [Related]

  • 3. Cognitive impairment in multiple sclerosis.
    Hoffmann S, Tittgemeyer M, von Cramon DY.
    Curr Opin Neurol; 2007 Jun; 20(3):275-80. PubMed ID: 17495620
    [Abstract] [Full Text] [Related]

  • 4. MRI markers of destructive pathology in multiple sclerosis-related cognitive dysfunction.
    Rovaris M, Comi G, Filippi M.
    J Neurol Sci; 2006 Jun 15; 245(1-2):111-6. PubMed ID: 16626748
    [Abstract] [Full Text] [Related]

  • 5. MRI correlates of cognitive dysfunction in multiple sclerosis patients.
    Rovaris M, Filippi M.
    J Neurovirol; 2000 May 15; 6 Suppl 2():S172-5. PubMed ID: 10871808
    [Abstract] [Full Text] [Related]

  • 6. Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study.
    Bergendal G, Fredrikson S, Almkvist O.
    Eur Neurol; 2007 May 15; 57(4):193-202. PubMed ID: 17272938
    [Abstract] [Full Text] [Related]

  • 7. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
    Sastre-Garriga J, Arévalo MJ, Renom M, Alonso J, González I, Galán I, Montalban X, Rovira A.
    J Neurol Sci; 2009 Jul 15; 282(1-2):120-4. PubMed ID: 19157420
    [Abstract] [Full Text] [Related]

  • 8. [Cognitive and emotional disorders in multiple sclerosis. Can a management strategy be envisioned?].
    Pelletier J, Benoit N, Montreuil M, Habib M.
    Pathol Biol (Paris); 2000 Mar 15; 48(2):121-31. PubMed ID: 10815288
    [Abstract] [Full Text] [Related]

  • 9. A comparison of memory performance in relapsing-remitting, primary progressive and secondary progressive, multiple sclerosis.
    Gaudino EA, Chiaravalloti ND, DeLuca J, Diamond BJ.
    Neuropsychiatry Neuropsychol Behav Neurol; 2001 Jan 15; 14(1):32-44. PubMed ID: 11234907
    [Abstract] [Full Text] [Related]

  • 10. Impact of individual cognitive profile on visuo-motor reorganization in relapsing-remitting multiple sclerosis.
    Gioia MC, Cerasa A, Liguori M, Passamonti L, Condino F, Vercillo L, Valentino P, Clodomiro A, Quattrone A, Fera F.
    Brain Res; 2007 Sep 05; 1167():71-9. PubMed ID: 17689504
    [Abstract] [Full Text] [Related]

  • 11. The association between cognitive impairment and quality of life in patients with early multiple sclerosis.
    Glanz BI, Healy BC, Rintell DJ, Jaffin SK, Bakshi R, Weiner HL.
    J Neurol Sci; 2010 Mar 15; 290(1-2):75-9. PubMed ID: 19944429
    [Abstract] [Full Text] [Related]

  • 12. Cognitive impairment in multiple sclerosis.
    Jongen PJ, Ter Horst AT, Brands AM.
    Minerva Med; 2012 Apr 15; 103(2):73-96. PubMed ID: 22513513
    [Abstract] [Full Text] [Related]

  • 13. Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis.
    Glanz BI, Holland CM, Gauthier SA, Amunwa EL, Liptak Z, Houtchens MK, Sperling RA, Khoury SJ, Guttmann CR, Weiner HL.
    Mult Scler; 2007 Sep 15; 13(8):1004-10. PubMed ID: 17623735
    [Abstract] [Full Text] [Related]

  • 14. Analysis of impairment related functional architecture in MS patients during performance of different attention tasks.
    Penner IK, Rausch M, Kappos L, Opwis K, Radü EW.
    J Neurol; 2003 Apr 15; 250(4):461-72. PubMed ID: 12700913
    [Abstract] [Full Text] [Related]

  • 15. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F, Amato MP, Trojano M, Bastianello S, Tola MR, Goretti B, Caniatti L, Di Monte E, Ferrazza P, Brescia Morra V, Lo Fermo S, Picconi O, Luccichenti G, COGIMUS Study Group.
    Mult Scler; 2009 Jul 15; 15(7):779-88. PubMed ID: 19542262
    [Abstract] [Full Text] [Related]

  • 16. Cognitive changes in multiple sclerosis.
    Amato MP, Zipoli V, Portaccio E.
    Expert Rev Neurother; 2008 Oct 15; 8(10):1585-96. PubMed ID: 18928350
    [Abstract] [Full Text] [Related]

  • 17. Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis.
    Benedict RH, Carone DA, Bakshi R.
    J Neuroimaging; 2004 Jul 15; 14(3 Suppl):36S-45S. PubMed ID: 15228758
    [Abstract] [Full Text] [Related]

  • 18. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
    Amato MP, Portaccio E, Stromillo ML, Goretti B, Zipoli V, Siracusa G, Battaglini M, Giorgio A, Bartolozzi ML, Guidi L, Sorbi S, Federico A, De Stefano N.
    Neurology; 2008 Aug 26; 71(9):632-8. PubMed ID: 18725589
    [Abstract] [Full Text] [Related]

  • 19. Magnetic resonance techniques to quantify tissue damage, tissue repair, and functional cortical reorganization in multiple sclerosis.
    Filippi M, Agosta F.
    Prog Brain Res; 2009 Aug 26; 175():465-82. PubMed ID: 19660674
    [Abstract] [Full Text] [Related]

  • 20. Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS.
    Morgen K, Sammer G, Courtney SM, Wolters T, Melchior H, Blecker CR, Oschmann P, Kaps M, Vaitl D.
    Neuroimage; 2006 Apr 15; 30(3):891-8. PubMed ID: 16360321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.